Research over the past two decades has uncovered an important role for extracellular LPA signaling and the LPA-metabolizing enzymes, ATX and LPP3, in energy homeostasis, insulin function, and obesity-induced metabolic complications. This evidence concerns the gene ENPP2 and obesity due to melanocortin 4 receptor deficiency.